(Part 3) The Risks of Psychedelics: Dr. Robert and The Downside of Psychedelic-Assisted Therapy

MindBody Matters

As part 3 of a miniseries on MindBody Matters, Greg interviews skeptic Dr. Robert about the controversial use of Psychedelic-Assisted therapy. Part 1 and 2 of the miniseries on psychedelics are discussed and Dr. Robert explains that if you use psychedelics and have a profound experience, even in a clinical trial, that its a delusion and just a hallucination, not real.

After the interview, Greg and Rob discuss if they are still believers or based on the interview, on the fence about the benefits of using psychedelics for mental health issues.

• Be a Patreon backer to get episodes early: patreon.com/MindBodyMatters Thanks to our supporters: sistonow23, expbull434, justin0977 !
• If you would like to be a guest on the show or to inquire about sponsorship/advertising, go to our website: mb-matters.com
• Artwork for MindBody Matters created by artist Mel Coleman ⁠https://www.instagram.com/melscoleman/⁠ or melcoleman.ca

Resources Mentioned:

For more information on how a variety of well validated, effective psychotherapy methods work, check out Dr. Robert's Treatment Toolkit, which is available for free at https://therapyonline.me/b/treatment-toolkit

The fall 2023 edition of Dr. Robert's newsletter contains an assortment of items he's written on this topic. It can be accessed by subscribing (for free) at https://therapyonline.me/blog/methods-and-mind-monthly

Steven Petrow (2023). I tried ketamine to treat my depression. It was terrifying. Washington Post, Perspective, February 12th edition.

https://www.washingtonpost.com/wellness/2023/02/12/ketamine-depression-treatment-failure/

Bordin ES (1979). The generalizability of the psychoanalytic concept of the working alliance. Psychotherapy. 16:252­60.

https://clinica.ispa.pt/ficheiros/areas_utilizador/user11/63._the_generalizability_of_the_psychoanalytic_concept_of_the_working_alliance.pdf

Wampold B & Fluckiger C (2023). The alliance in mental health care: conceptualization, evidence, and clinical applications. World Psychiatry, 22:1, 25-41 DOI:10.1002/wps.21035

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840508/pdf/WPS-22-25.pdf

---

Hosted on Acast. See acast.com/privacy for more information.